BioAdaptives Inc. Convertible Notes Payable, Current
BioAdaptives Inc. (BDPT) had Convertible Notes Payable, Current of $490.63 thousand as of 2026-06-30, per its 10-Q filed 2026-08-19.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Notes Payable, Current
us-gaap:ConvertibleNotesPayableCurrent · last filed 2026-08-19
- 2026-06-30: Convertible Notes Payable, Current $490.63K.
- 2026-03-31: Convertible Notes Payable, Current $424.21K.
- 2025-12-31: Convertible Notes Payable, Current $352.33K.
- 2025-09-30: Convertible Notes Payable, Current $359.30K.
| Period end | Convertible Notes Payable, Current | Convertible Notes Payable, Current as first filed |
|---|---|---|
| 2026-06-30 | $490.63K 10-Q · filed 2026-08-19 | |
| 2026-03-31 | $424.21K 10-Q · filed 2026-05-15 | |
| 2025-12-31 | $352.33K 10-Q · filed 2026-08-19 | |
| 2025-09-30 | $359.30K 10-Q · filed 2025-11-14 | |
| 2025-06-30 | $311.00K 10-Q · filed 2025-08-14 | |
| 2025-03-31 | $311.00K 10-Q · filed 2025-05-13 | |
| 2024-12-31 | $461.00K 10-K · filed 2026-04-14 | $311.00K 10-K · filed 2025-04-15 |
| 2024-06-30 | $311.00K 10-Q · filed 2024-08-19 | |
| 2024-03-31 | $314.10K 10-Q · filed 2024-05-17 | |
| 2023-12-31 | $321.66K 10-K · filed 2025-04-15 | |
| 2023-09-30 | $325.67K 10-Q · filed 2023-11-13 | |
| 2023-06-30 | $315.74K 10-Q · filed 2023-08-11 | |
| 2023-03-31 | $347.34K 10-Q · filed 2023-05-12 | |
| 2022-12-31 | $381.79K 10-K · filed 2024-04-10 | |
| 2022-09-30 | $423.89K 10-Q · filed 2022-11-14 | |
| 2022-06-30 | $440.01K 10-Q · filed 2022-08-12 | |
| 2022-03-31 | $407.91K 10-Q · filed 2022-05-12 | |
| 2021-12-31 | $403.12K 10-K · filed 2023-03-31 | |
| 2021-09-30 | $446.22K 10-Q · filed 2021-11-10 | |
| 2021-06-30 | $479.28K 10-Q · filed 2021-08-12 | |
| 2021-03-31 | $391.60K 10-Q · filed 2021-05-14 | |
| 2020-12-31 | $405.24K 10-K · filed 2022-03-31 | |
| 2020-09-30 | $386.33K 10-Q · filed 2020-11-16 | |
| 2020-06-30 | $352.47K 10-Q · filed 2020-08-13 | |
| 2020-03-31 | $393.52K 10-Q/A · filed 2020-06-11 | |
| 2019-12-31 | $312.89K 10-K · filed 2021-03-30 | |
| 2019-09-30 | $204.13K 10-Q · filed 2019-11-07 | |
| 2019-06-30 | $147.43K 10-Q · filed 2019-08-14 |